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A B S T R A C T
This is the protocol for a review and there is no abstract. The objectives are as follows:
The aim of this review is to evaluate the evidence from randomised controlled trials for the non-surgical intervention of paediatric pes
planus.
B A C K G R O U N D
Pes planus (flatfoot) is one of the most common conditions ob-
served in paediatric health practice (Luhmann 2000; Sullivan
1999). The prevalence of paediatric pes planus has been reported
to be between 2.7% and 12.3% (Garcia 1999). There is no uni-
versally accepted definition for pes planus. Clinically, a pes planus
is one that has a low or absent longitudinal arch. A flexible flat
foot will have an arch that is present in open kinetic chain (non-
weight-bearing) and lost in closed kinetic chain (weight-bearing).
A rigid flatfoot has loss of the longitudinal arch height in open
and closed kinetic chain (Napolitano 2000). Normally developing
infants have a flexible flatfoot and gradually develop a normal arch
during the first decade of life (Capello 1998).
There is a wide spectrum of severity andmany different aetiologies
for paediatric pes planus (Capello 1998). Staheli 1987 proposed
a generic classification of flatfoot deformities that differentiated
between flatfeet due to physiological and pathological aetiologies.
Harris 2004 reported that pes planus may exist as an isolated
pathology or as part of a larger clinical pathologies such as gen-
eralised ligamentous laxity, neurological and muscular abnormal-
ities, genetic conditions and syndromes, and collagen disorders.
Luhmann 2000 states that tarsal coalitions are the most common
cause of rigid flatfeet in children and adolescents. Napolitano 2000
reported that obesity, rotational deformities producing in-toeing
or out-toeing, accessory naicular, ankle equinus, varus and valgus
deformities of the tibia and its relationship to the weight-bearing
surface, are risk factors that may play a role in the development
and function of the foot.
Notwithstanding the underlying pathology of pes planus, there are
conflicting opinions on the intervention of paediatric pes planus
(Garcia 1999). The primary goals of treatment of flatfeet are re-
lief of pain or disability and the prevention of future disability
(Capello 1998). While some experts consider that pes planus is
normal in early childhood and that the condition usually resolves
spontaneously without treatment (Brooks 1991; Volpon 1994),
others experts suggest treating the flexible form of pes planus is
necessary as it may lead to disability, joint damage and in later life
a rigid fixed foot deformity (Aharonson 1992; Connors 1998).
The American College of Foot and Ankle Surgeons (Harris 2004)
have published clinical practice guidelines for the diagnosis and
treatment of paediatric pes planus. An overriding concern is that
flatfoot can cause debilitating foot pain in adults and should be
diagnosed early and treated appropriately. The controversy about
the management of pes planus arises from the contradictory opin-
ions expressed by different authors. Luhmann 2000 reported that
a rigid pes planus is often symptomatic and requires treatment. A
flexible pes planus may be either asymptomatic or symptomatic
(Sullivan 1999). Luhmann 2000 suggested that the flexible type is
a common diagnosis and is one which is usually not problematic
and rarely needs treatment. The treatment of this condition can
vary from conservative management to surgical approaches. The
latter are used rarely and generally only after failure of conserva-
tive management. A plethora of conservative (non-surgical) inter-
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ventions have been reported in the literature ranging from advice
to foot orthoses (shoe inserts), stretching, footwear selection and
modifications, activitymodifications, manipulation, serial casting,
appropriate weight reduction and anti-inflammatory medications.
Hence, there is a need to identify and evaluate the evidence from
randomised trials of non-surgical interventions used in the man-
agement paediatric pes planus.
O B J E C T I V E S
The aim of this review is to evaluate the evidence from randomised
controlled trials for the non-surgical intervention of paediatric pes
planus.
C R I T E R I A F O R C O N S I D E R I N G
S T U D I E S F O R T H I S R E V I E W
Types of studies
All randomised controlled trials (RCTs) and quasi-randomised
controlled clinical trials (CCTs; methods of allocating participants
to a treatment which are not strictly random, e.g., date of birth,
hospital record number or alternation) comparing non-surgical
interventions versus placebo, sham or no intervention (control) or
other non-surgical interventions for paediatric pes planus.
Types of participants
Since there is no universally accepted definition for pes planus,
pes planus in this review is a term that will be used to describe a
recognizable clinical deformity created by malalignment at several
adjacent joints. Included will be trials with participants meeting
the following criteria: children under 16 years old and pes planus
pain for greater than eight weeks duration. Studies of various soft
tissue diseases and pain due to tendinitis at all sites will be included
provided that the pes planus pain results are presented separately
or greater than 90% of participants in the study had pes planus
pain. We will also include those studies whose participants have
plantar heel pain, stress fractures of the metatarsals, ankle frac-
tures, rheumatoid foot pathologies, diabetic foot, or neuromuscu-
lar conditions. Studies focusing on children with Down’s, Marfans
or ’Ehlers-Danlos’ syndrome will also be included.
Types of intervention
These include activity modification, manipulation, serial casting,
weight reduction, anti-inflammatory medication, rigid, semi-rigid
or soft-foot orthoses designed to provide support or pain relief,
or both at the subtalar joint; corrective footwear; anti-pronatory
strapping; stretching exercises; and educational advice to children
or their parents and guardians. Excluded will be studies involving
surgical intervention.
Types of outcome measures
Primary outcomes:
• Pain reduction
Secondary outcomes:
• Function/disability indices of the foot
• Goniometric measurement or those that are collated in a gait
laboratory that includes both kinetic and kinematic data
• Quality of life measures
• Adverse effects of treatment interventions under test
• Patient comfort
S E A R C H M E T H O D S F O R
I D E N T I F I C A T I O N O F S T U D I E S
See: Cochrane Musculoskeletal Group methods used in reviews.
Eligible studies will be sought from electronic searches of the
Cochrane Central Register of Controlled Trials (CENTRAL),
MEDLINE, EMBASE, CINAHL, INDEX TO THESIS, and
DISSERTATION ABSTRACTS. In MEDLINE, subject specific
search terms will be combined with the optimum search strategy
for randomised trials described by Robinson 2002 (see Table 01)
The electronic search will be complemented by the following:
• checking of reference lists of relevant articles for additional
studies reported in published papers, scientific meetings, and
personal communications;
• downloads of Current Contents up to January 2007;
• hand searches of abstracts published in special issues of
specialised journals or in conference proceedings;
• contact of content experts for additional studies and
unpublished data.
M E T H O D S O F T H E R E V I E W
Study identification and selection
One author (KR) will check through the titles and abstracts
identified by the above searches and identify potentially eligible
studies for obtaining full trial reports and study selection. The
results of study selection by KR will be checked by one of the
two other authors (RA and AE). Disagreement will be resolved by
consensus or third party adjudication (KR).
Quality assessment of the included trials
Methodological quality for each study will be assessed
independently, without masking (Jahad 1996; Schulz 1994;
Verhagen 1998), by two reviewers (RA, AE) from the group using a
piloted, subject-specificmodificationof the generic evaluation tool
used by theCochraneMusculoskeletal Group. The scoring scheme
for the 11 items of internal and external validity is outlined inTable
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02. There are three potential ratings: (i) meets; (ii) partially meets;
and (iii) does not meet each validity criterion. The assessment
of each criterion will be presented in the review, and an overall
assessment of the validity of the results of individual trials will also
be assessed by assigning one of three categories- low, moderate,
and high risk of bias- corresponding to all criteriamet, one ormore
criteria partially met, and one or more criteria not met. Allocation
concealment will also be ranked as: A: adequate; B: unclear; C:
inadequate; or D: not used. Any disagreement will be resolved by
consensus or third party adjudication (KR).
Data extraction
The three authors will independently extract data and study details
using a standard pre-designed form.Disagreement will be resolved
by consensus or third party adjudication (KR). We will contact
authors of trials if there is incomplete reporting of data.
Data analysis
For each study, we will calculate relative risks and 95% confidence
limits for dichotomous outcomes, and we will compute weighted
mean differences and 95% confidence limits for continuous
outcomes.Wewill conductmeta-analyseswith a fixed-effectmodel
if studies are clinically and statistically homogenous. Where there
is statistical evidence of heterogeneity (a chi-squared test with P
< 0.10 or an I2test with a percentage of the variability in effect
estimates >50%), we will used a random effects model.
Clinical Relevance Tables
Clinical relevance tables will be compiled under additional tables
to improve the readability of the review. For dichotomous
outcomes, like complications, the number needed to treat will be
calculated from the control group event rate and the relative risk
using the Visual Rx NNT calculator (Cates 2003). Continuous
outcome tables will also be presented under additional tables.
Absolute benefit will be calculated as the improvement in the
intervention group minus the improvement in the control group,
in the original units. Relative difference in the change frombaseline
will be calculated as the absolute benefit divided by the baseline
mean of the control group.
Grading of the evidence
A further ranking based on the level of evidence will be performed
in the manner described by Tugwell 2004 and approved by the
CMSG editorial team. A simplified ranking will be used to grade
the strength of scientific evidence for the trial intervention. In
decreasing order:
Platinum: A published systematic review that has at least two
individual controlled trials each satisfying the following:
• Sample sizes of at least 50 per group - if these do not find a
statistically significant difference; they are adequately powered
for a 20% relative difference in the relevant outcome.
• Blinding of patients and assessors for outcomes.
• Handling of withdrawals >80% follow up (imputations based
on methods such as Last Observation Carried Forward (LOCF)
are acceptable).
• Concealment of treatment allocation.
Gold: At least one randomised clinical trial meeting all of the
following criteria for the major outcome(s) as reported:
• Sample sizes of at least 50 per group - if these do not find a
statistically significant difference; they are adequately powered
for a 20% relative difference in the relevant outcome.
• Blinding of patients and assessors for outcomes.
• Handling of withdrawals > 80% follow up (imputations based
on methods such as LOCF are acceptable).
• Concealment of treatment allocation.
Silver: A randomised trial that does not meet the above criteria.
Silver ranking would also include evidence from at least one
study of non-randomised cohorts that did and did not receive the
therapy, or evidence from at least one high quality case-control
study. A randomised trial with a ’head-to-head’ comparison of
agents would be considered silver level ranking unless a reference
were provided to a comparison of one of the agents to placebo
showing at least a 20% relative difference.
Bronze: The bronze ranking is given to evidence if at least
one high quality case series without controls (including simple
before/after studies in which patients act as their own control) or
if the conclusion is derived from expert opinion based on clinical
experience without reference to any of the foregoing (for example,
argument from physiology, bench research or first principles).
P O T E N T I A L C O N F L I C T O F
I N T E R E S T
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A D D I T I O N A L T A B L E S
Table 01. MEDLINE (OVID-WEB) search strategy
MEDLINE (OVID-WEB)
1. exp flatfoot/
2. flat foot$.mp.
3. flatfoot$.mp.
4. flat feet.mp.
5. flatfeet.mp.
6. pes planus.mp.
4Non-surgical interventions for paediatric pes planus (Protocol)
Copyright © 2008 The Cochrane Collaboration. Published by John Wiley & Sons, Ltd
Table 01. MEDLINE (OVID-WEB) search strategy (Continued )
MEDLINE (OVID-WEB)
7. painful foot.mp.
8. pes planovalgus.mp.
9. posterior tibial tendon dysfunction.mp.
10. subtalar.mp.
11. (sub$ adj talar).mp.
12. calcane$.mp.
13. heel bone$.mp.
14. medical arch$2.mp.
15. or/1-14
16. exp musculoskeletal diseases/
17. exp neuromuscular diseases/
18. exp nervous system diseases/
19. ehlers-danlos.mp.
20. down$ syndrome.mp.
21. trisomy.mp.
22. mongolism.mp.
23. inflammatory arthritis.tw.
24. (juvenile adj3 arthritis).tw.
25. or/16-24
26. exp diabetes mellitus, type 1/
27. (diabet$ or IDDM).tw.
28. 26 or 27
29. exp diabetes insipidus/
30. mellitus.tw.
31. 29 not (26 or 30)
32. (diabet$ adj (insipidus not mellitus)).tw.
33. 31 or 32
34. 28 not 33
35. joint instability.sh.
36. ligament$ laxity.mp.
37. pronat$.mp.
38. malalignment.mp.
39. or/35-38
40. or/25,34,39
41. 15 and 40
42. randomized controlled trial.pt.
43. controlled clinical trial.pt.
44. randomized controlled trials.sh.
45. random allocation.sh.
46. double blind method.sh.
47. single-blind method.sh.
48. clinical trial.pt.
49. clinical trials.sh.
50. clinical trial.tw.
51. ((singl$ or doubl$ or trebl$ or tripl$) and (mask$ or blind$)).tw.
52. placebos.sh.
53. placebo$.tw.
54. random$.tw.
55. research design/
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Table 01. MEDLINE (OVID-WEB) search strategy (Continued )
MEDLINE (OVID-WEB)
56. comparative study.sh.
57. evaluation studies.sh.
58. follow-up studies.sh.
59. prospective studies.sh.
60. control$.tw.
61. prospectiv$.tw.
62. volunteer$.tw.
63. or/42-62
64. (animal not human).mp.
65. 63 not 64
66. 41 and 65
67. limit 66 to (“infant (1 to 23 months)” or “preschool child (2 to 5 years)” or “child (6 to 12 years)” or “adolescent (13 to 18 years)”)
68. child.mp.
69. children.mp.
70. childhood.mp.
71. infant$.mp.
72. teenag$.mp.
73. adolescen$.mp.
74. paediatric.mp.
75. pediatric.mp.
76. or/68-75
77. 66 and 76
78. 67 or 77
Table 02. Methodological assessment tool
Quality criterion Scores
1. Was the assigned treatment adequately concealed prior to allocation? Meets, Partially meets, Does not meet
2. Were the outcomes of patients who withdrew described and included in the analysis
(intention to treat)?
Meets, Partially meets, Does not meet
3. Were the outcome assessors blinded to treatment status? Meets, Partially meets, Does not meet
4. Were the treatment and control group comparable at entry? Meets, Partially meets, Does not meet
5. . Were the subjects blind to assignment status after allocation? Meets, Partially meets, Does not meet
6. Were the treatment providers blind to assignment status after allocation? Meets, Partially meets, Does not meet
7. Were care programmes, other than the trial options, identical? Meets, Partially meets, Does not meet
8. Were the inclusion and exclusion criteria clearly defined? Meets, Partially meets, Does not meet
9. Were the outcome measures used clearly defined? Meets, Partially meets, Does not meet
10. Was follow-up active and appropriate? Meets, Partially meets, Does not meet
11. Was the duration of surveillance clinically appropriate? Meets, Partially meets, Does not meet
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